HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A Lebecq Selected Research

RPR 109881A

7/2002Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors.
12/2000Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A Lebecq Research Topics

Disease

3Neoplasms (Cancer)
07/2002 - 10/2000
1Pleural Effusion (Pleural Effusions)
07/2002
1Renal Cell Carcinoma (Grawitz Tumor)
12/2000
1Adenocarcinoma
05/2000

Drug/Important Bio-Agent (IBA)

2RPR 109881AIBA
07/2002 - 12/2000
2Docetaxel (Taxotere)FDA Link
10/2000 - 05/2000
1Taxoids (Taxanes)IBA
07/2002
1Biological ProductsIBA
07/2002
1taxaneIBA
12/2000
1Pharmaceutical PreparationsIBA
12/2000
1Irinotecan (Camptosar)FDA LinkGeneric
10/2000

Therapy/Procedure

1Intravenous Infusions
12/2000
1Drug Therapy (Chemotherapy)
05/2000